Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: D.Right who wrote (1070)	1/30/1998 3:02:00 PM
From: Don S.Boller	Read Replies (1) \| Respond to of 2173

D. YOU ARE CORRECT ABOUT THE 75% ON PRAM I should have mentioned this in my post # 1045. It was in the CA Tech Stock Newslwtter of 1/23/98. Sorry 'bout that. Best, Don

To: D.Right who wrote (1070)	1/30/1998 7:24:00 PM
From: Harry Ehrlich	Read Replies (2) \| Respond to of 2173

I don't know much abpout the medical aspects of Amylin's product. But the chart looks good from a technical point of view. The bottom point we saw a few days ago was a classic bottom. In candlestick terminology it's called a hammer. I know it as a "lizard". It's that classic "t" shaped daily bar. It happened under high volume. This is an indication that the selling pressure has exhausted itself and the buyers are coming in. The confirmation occurred the next day when AMLN continued to rise. I don't expect anything spectacular in the near term, as AMLN has a long way to go with its program. But I believe the street is always looking to find a fair valuation for a stock. That number should be between 4+ and 8, which are the recent low and high levels. My feeling is that anything bought in the low 5 range will be a good hold for the future, as there may not be too much downside from here. Even if you have to hold for a long time, if the stock settles in at 6 and you bought at 5, there will be no pain in holding. Just my thoughts. Harry

To: D.Right who wrote (1070)	1/31/1998 10:53:00 PM
From: Harry Ehrlich	Read Replies (1) \| Respond to of 2173

>If something doesn't help you much, will you inject it for a year even if it is free?< Again, I study the charts from a technical point of view, but I don't know much about the medical aspects of AMLN's product. But I thought they were working on an oral medication for diabetes. You mention above that they inject it. Please clarify for me. Thanks. Harry

To: D.Right who wrote (1070)	2/12/1998 5:25:00 PM
From: arnie h	Read Replies (1) \| Respond to of 2173

Dear D.- Back on the matter of 75% continuing on pramlintide post trial. Based on the results released, there were 2 groups of type 2 patients who entered the study with poor glucose control but maintained stable insulin dosing; one had dosage of 75 mcg and the other 150 mcg. Reductions in HbAlc were impressive in both but were not statistically significant because of the very small size of the groups (23 and 20). If 75 % of these folks stayed with pramlintide, it would be most encouraging. Is there a way of learning whether this is so? I don't know of any reason this information should be confidential and may well be available. Would appreciate your (or others) thoughts on how to get this info and it's possible significance. Thank you, Arnie